• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚西部卫生部耐药监测项目中疑似耐多药结核病患者中非结核分枝杆菌的分布情况。

Distribution of nontuberculous Mycobacteria among presumptive drug resistance tuberculosis patients from a ministry of health drug resistance surveillance program, in western Kenya.

作者信息

Albert Okumu, Lazarus Odeny, Benjamin Ochieng John, Ben Odhiambo, Ruth Sitati, Joan Tonui, Jeremiah Ogoro, Steve Wandiga, Ouma Collins

机构信息

Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.

Maseno University, School of Public and Community Development, Department of Biomedical Sciences and Technology, Kisumu, Kenya.

出版信息

J Clin Tuberc Other Mycobact Dis. 2025 Aug 19;41:100559. doi: 10.1016/j.jctube.2025.100559. eCollection 2025 Dec.

DOI:10.1016/j.jctube.2025.100559
PMID:40895129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12396555/
Abstract

INTRODUCTION

Nontuberculous Mycobacteria (NTM) species are emerging pathogens causing Pulmonary diseases with no definitive treatment. Molecular techniques enable characterization and drug resistance profiling, this study sought to determine NTM prevalence, circulating species, and distribution factors among presumptive multidrug-resistant tuberculosis (MDR-TB) patients in western Kenya.

METHOD

Sputum samples were collected between March through October 2022, and transported for testing at Kenya Medical Research Institute (KEMRI) TB laboratory, in Kisumu. The standard NALC-NaOH MGIT culture technique, smear, HAIN AS/CM and NTM drug resistance were carried out.

RESULTS

Of the 155 specimens analyzed, 106 (68.4 %) were males, 41 (26.5 %) HIV positive, and participants of ages 36-45 years, the majority. An overall NTM prevalence of 99 (63.9 %), of whom 63 (63 %) among males reported. In addition, 11 NTM species identified, with (44, 44 %).

CONCLUSIONS

High prevalence of NTM species was observed among middle-aged males and HIV negative participants, Kisumu led in distribution (29 %) and among HIV positive. The NTM prevalence among smear negative vs smear positive, was significant a p < 0.001, hence adequate TB/HIV integration and management, use of molecular techniques, and accurate identification is critical.

摘要

引言

非结核分枝杆菌(NTM)是新兴的病原体,可导致肺部疾病,且尚无明确的治疗方法。分子技术能够进行特征鉴定和耐药性分析,本研究旨在确定肯尼亚西部疑似耐多药结核病(MDR-TB)患者中NTM的流行情况、流行菌株及其分布因素。

方法

于2022年3月至10月期间采集痰液样本,并送往位于基苏木的肯尼亚医学研究所(KEMRI)结核病实验室进行检测。采用标准的NALC-NaOH MGIT培养技术、涂片检查、HAIN AS/CM检测及NTM耐药性检测。

结果

在分析的155份样本中,男性有106份(68.4%),41份(26.5%)为HIV阳性,参与者年龄大多在36 - 45岁之间。NTM总体流行率为99份(63.9%),其中男性报告有63份(63%)。此外,鉴定出11种NTM菌株,其中[此处原文缺失具体内容](44份,44%)。

结论

在中年男性和HIV阴性参与者中观察到NTM菌株的高流行率,基苏木在分布方面占主导(29%)且在HIV阳性者中也是如此。涂片阴性与涂片阳性患者中的NTM流行率差异显著,p < 0.001,因此充分整合和管理结核病/HIV、使用分子技术以及准确鉴定至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0956/12396555/b4db910e0ca1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0956/12396555/fe045156085d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0956/12396555/b4db910e0ca1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0956/12396555/fe045156085d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0956/12396555/b4db910e0ca1/gr2.jpg

相似文献

1
Distribution of nontuberculous Mycobacteria among presumptive drug resistance tuberculosis patients from a ministry of health drug resistance surveillance program, in western Kenya.肯尼亚西部卫生部耐药监测项目中疑似耐多药结核病患者中非结核分枝杆菌的分布情况。
J Clin Tuberc Other Mycobact Dis. 2025 Aug 19;41:100559. doi: 10.1016/j.jctube.2025.100559. eCollection 2025 Dec.
2
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核及利福平耐药性的Xpert® MTB/RIF检测法
Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3.
3
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核和利福平耐药性的Xpert® MTB/RIF检测
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
4
Non-tuberculous mycobacterial infections among pulmonary tuberculosis suspected and confirmed patients in Ethiopia - A systematic review and meta analyses.埃塞俄比亚疑似和确诊肺结核患者中的非结核分枝杆菌感染——一项系统评价和荟萃分析
BMC Infect Dis. 2025 Aug 28;25(1):1078. doi: 10.1186/s12879-025-11497-y.
5
Treatment outcomes of multi-drug-resistant and rifampicin-resistant tuberculosis with and without isolation of nontuberculous mycobacteria between 2018-2021: A retrospective cohort study in Ghana.2018 - 2021年期间有无非结核分枝杆菌分离的耐多药和耐利福平结核病的治疗结果:加纳的一项回顾性队列研究
PLoS Negl Trop Dis. 2025 Jul 2;19(7):e0013204. doi: 10.1371/journal.pntd.0013204. eCollection 2025 Jul.
6
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
7
Negligible clinical impact of subsequent non-tuberculous mycobacteria isolation during MDR/RR-TB treatment: a 9-year retrospective cohort study from Wenzhou, China.耐多药/利福平耐药结核病治疗期间后续非结核分枝杆菌分离的临床影响可忽略不计:来自中国温州的一项9年回顾性队列研究
BMC Infect Dis. 2025 Jul 24;25(1):942. doi: 10.1186/s12879-025-11336-0.
8
Simultaneous detection and differentiation of and nontuberculous mycobacteria in smear-negative sputum by a multiplex PCR assay: a clinical feasibility study.通过多重聚合酶链反应检测方法同时检测和鉴别涂片阴性痰液中的结核分枝杆菌和非结核分枝杆菌:一项临床可行性研究。
Microbiol Spectr. 2025 Jul;13(7):e0231624. doi: 10.1128/spectrum.02316-24. Epub 2025 May 30.
9
Species diversity and clinical relevance of nontuberculous mycobacterium isolated from pulmonary and extrapulmonary samples in southeastern Turkey, 2014 to 2023: A retrospective cross-sectional study.2014年至2023年土耳其东南部肺和肺外样本中分离出的非结核分枝杆菌的物种多样性及临床相关性:一项回顾性横断面研究
Medicine (Baltimore). 2025 Jul 18;104(29):e43415. doi: 10.1097/MD.0000000000043415.
10
Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.从南非金矿工人痰液中分离出的非结核分枝杆菌的临床相关性:一项观察性临床研究
Biomed Res Int. 2015;2015:959107. doi: 10.1155/2015/959107. Epub 2015 May 28.

本文引用的文献

1
Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB.疑似/确诊耐多药结核病中NTM的患病率及预测因素
IJTLD Open. 2024 Jul 1;1(7):306-313. doi: 10.5588/ijtldopen.24.0242. eCollection 2024 Jul.
2
Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification.分子诊断学的应用和进展:革新非结核分枝杆菌种和亚种鉴定。
Front Public Health. 2024 Jun 19;12:1410672. doi: 10.3389/fpubh.2024.1410672. eCollection 2024.
3
Prevalence of Non-Tuberculosis Mycobacterium Pulmonary Disease in HIV-1 Patients with Presumptive Pulmonary Tuberculosis in Western Kenya.
在肯尼亚西部,有疑似肺结核的 HIV-1 患者中,非结核分枝杆菌肺病的流行情况。
Ethiop J Health Sci. 2023 Sep;33(5):735-742. doi: 10.4314/ejhs.v33i5.3.
4
Laboratory tests and analysis of drug resistance in non-tuberculous mycobacteria.非结核分枝杆菌的实验室检测及耐药性分析
Heliyon. 2024 Mar 27;10(7):e28665. doi: 10.1016/j.heliyon.2024.e28665. eCollection 2024 Apr 15.
5
Unveiling the Clinical Diversity in Nontuberculous Mycobacteria (NTM) Infections: A Comprehensive Review.揭示非结核分枝杆菌(NTM)感染的临床多样性:一项综合综述
Cureus. 2023 Nov 4;15(11):e48270. doi: 10.7759/cureus.48270. eCollection 2023 Nov.
6
Sex and Gender Differences in Tuberculosis Pathogenesis and Treatment Outcomes.结核病发病机制和治疗结局中的性别差异。
Curr Top Microbiol Immunol. 2023;441:139-183. doi: 10.1007/978-3-031-35139-6_6.
7
biofilms.生物膜
Biofilm. 2023 Feb 7;5:100107. doi: 10.1016/j.bioflm.2023.100107. eCollection 2023 Dec.
8
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.全球非结核分枝杆菌肺部感染的趋势:一项系统评价。
Int J Infect Dis. 2022 Dec;125:120-131. doi: 10.1016/j.ijid.2022.10.013. Epub 2022 Oct 13.
9
Non-tuberculous mycobacteria pulmonary disease: A review of trends, risk factors, diagnosis and management.非结核分枝杆菌肺病:趋势、危险因素、诊断与管理综述
Afr J Thorac Crit Care Med. 2022 Jul 15;28(2). doi: 10.7196/AJTCCM.2022.v28i2.157. eCollection 2022.
10
Comorbidities of nontuberculous mycobacteria infection in Korean adults: results from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database.韩国成年人中分枝杆菌感染的合并症:来自国家健康保险服务-国家样本队列(NHIS-NSC)数据库的结果。
BMC Pulm Med. 2022 Jul 23;22(1):283. doi: 10.1186/s12890-022-02075-y.